Home
>
National Drug Code (NDC)
>
Naprosyn
Naprosyn - 0004-0028-28 - (naproxen)
Drug Information of Naprosyn
| Product NDC: | 0004-0028 |
| Proprietary Name: | Naprosyn |
| Non Proprietary Name: | naproxen |
| Active Ingredient(s): | 125 mg/5mL & nbsp; naproxen |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Naprosyn
| Product NDC: | 0004-0028 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018965 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19870323 |
Package Information of Naprosyn
| Package NDC: | 0004-0028-28 |
| Package Description: | 473 mL in 1 BOTTLE, PLASTIC (0004-0028-28) |
NDC Information of Naprosyn
| NDC Code | 0004-0028-28 |
| Proprietary Name | Naprosyn |
| Package Description | 473 mL in 1 BOTTLE, PLASTIC (0004-0028-28) |
| Product NDC | 0004-0028 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | naproxen |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 19870323 |
| Marketing Category Name | NDA |
| Labeler Name | Genentech, Inc. |
| Substance Name | NAPROXEN |
| Strength Number | 125 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
